Facebook
X
LinkedIn
ForwardInaugural Tri-State Pulmonary Hypertension Symposium
The Inaugural Tri-State Pulmonary Hypertension Symposium is a premier educational conference designed to bring together healthcare professionals from across the tri-state region to advance the care of patients living with Pulmonary Hypertension. Through expert-led presentations, case-based discussions, and opportunities for networking, attendees will explore the best practices, emerging therapies, clinical research, and innovative approaches for managing pulmonary hypertension.
Target Audience
Primary Care Physicians, Advanced Practice Providers, General and Non-invasive Cardiologists, Pulmonologists, Rheumatologists, Nurses, Exercise Physiologists, Echocardiographers, and Respiratory Therapists.
Learning Objectives
1. Recognize the importance of early diagnosis and referral in improving patient outcomes.
2. Describe the general diagnostic pathway and the role of specialized centers in confirming pulmonary hypertension.
3. Identify key signs and symptoms of Pulmonary Hypertension.
4. Discuss the role of combination therapy, disease-modifying agents, and supportive care in managing pulmonary hypertension.
5. Identify common complications associated with pulmonary hypertension and their management.
6. Recognize situations requiring urgent specialist consultation or hospital admission for patients with established pulmonary hypertension.
Course summary
Time | Speaker | Topic | Speaker |
0800-0900 | Breakfast, vendor face-time | PRODUCT THEATER |
|
0900 | Brief introduction, with introduction of first moderator and speaker |
|
|
0900 am sessions | WHO 1: Moderators Ray Benza | ||
0900-0915 | Case 1: IPAH or HPAH patient | Epidemiology, prevalence, initial presentation, symptoms, RISK assessment and follow up | Veronica Franco, MD |
0915-0930 | Case 2: CTD | Diagnostic approach including TTE, 6 MWT, PFT w DLCO, DETECT algorithm | Kristin Highland, MD |
0930-0945 | Case 3: PoPH | Hemodynamic limitations and impact on therapy, and timing and screening for cirrhosis and how it affects transplant candidacy | Andrew Pogozelski, MD |
0945-1000 | Case 4: CHD | 7th decade of life, ASD, imaging modalities -bubble, +/- TEE, CMRI, and treatment prior to closure and follow up hemodynamics and imaging | Nael Aldweib, MD |
1000-1015 | Case 5: Drug induced | Risks versus benefits of ongoing chemotherapy, treatment with PH specific therapies while being treated for underlying cancer | Marco Caccamo, MD |
1015-1030 | PANEL |
| Panelists: Veronica Kristin Jim Marco Nael |
1030-1045 break |
| ||
1045 am sessions | WHO GROUP 2 Moderator: Hayah Kassis-George, MD | ||
1045-1100 | WHO GROUP 2
Case: mitral valve replacement in RHD, with residual severe PH years later |
Treatment dilemmas in who group 2 Possible use of Winrevair | Hayah Kassis-George, MD |
1100-1115 | Case 2: HFpEF | Echocardiographic nuances of left heart disease confounding PH screening | Amresh Raina, MD |
1115 am sessions | WHO GROUP 3 MODERATOR: Tariq Cheema, MD | ||
1115-1130 | Case 1: OHS, OSA | Importance of ABG, sleep study, weight loss | Christian Kyung, MD (Jefferson) |
1130-1145 | Case 2: ILD | Importance of imaging and accurate diagnosis, impacting prognosis and treatment | Timothy Mickus, MD |
1145-1200 | Panel discussion |
| Christian Kyung, MD Timothy Mickus, MD
|
1200-1245 pm | LUNCH | Guest Speaker Ray Benza, MD | TOPIC OF CHOICE |
1245 pm sessions | WHO group 4 MODERATOR: Bilal Jalil, MD | ||
1245-100 pm | WHO group 4
Case 1: surgical patient
|
| Candice Lee, MD |
100 pm – 115 pm | Case 2: non-surgical patient, meds+BPA |
| Mithun Chakravarthy, MD |
115-130 | PANEL Discussions |
| Panelists: Bilal Candice Mithun |
130-145 break |
| ||
145 pm sessions | CCM Issues in RHC: MODERATOR: BRIANA DISILVIO, MD | ||
145-200 pm | Case 1: RHF
|
| Kyle Kapcin, DO |
200-215 pm | Case 2: To support or not to support RVF in PAH | MCS, ECMO in particular in PAH. CI Tandem and RPella | Karthik Ranganathan, MD |
215-230pm | Timing for Lung Transplantation Eval |
| Michael Risbano, MD |
230-245 pm | Supportive care | (asked Craig to speak or help find a speaker) | Craig Alpert, MD |
245-300 pm | Cardiac rehab, pulmonary rehab |
| TBD |
300-315pm | Panel discussion |
| Panelists: Jalil Briana Karthik Michael Craig |
315 pm |
| ||
Physicians
Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Allegheny General Hospital designates this live activity for a maximum of XX AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation
in this activity.